A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 52-Week Study to Evaluate the Efficacy/Safety of Transdermal Patches Delivering Testosterone in Menopausal Women With Low Libido Not Receiving Estrogen Therapy.

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 52-Week Study to Evaluate the Efficacy/Safety of Transdermal Patches Delivering Testosterone in Menopausal Women With Low Libido Not Receiving Estrogen Therapy.

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Apr 2013

At a glance

  • Drugs Testosterone (Primary)
  • Indications Decreased libido
  • Focus Registrational; Therapeutic Use
  • Acronyms APHRODITE
  • Sponsors Procter & Gamble
  • Most Recent Events

    • 30 Mar 2010 Warner Chilcott added as trial sponsor and trial affiliate as reported by ClinicalTrials.gov.
    • 06 Nov 2008 Results have been published in the NEJM.
    • 04 Sep 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top